Web Exclusive
Nifty's short-term trend has turned bullish: Nandish Shah of HDFC Sec

Nifty outlook

The short-term trend of the Nifty has turned bullish as it closed above its 5- and 20-day EMA. Nifty has broken out on the daily line chart on Tuesday where it closed at highest level since March 16, 2021. Oscillators like RSI and MFI have broken out from the downward slopping trendline, indicating strength in the current rally. Therefore, our advice is to remain bullish and accumulate long positions with the stop loss of 14,500 level. On the higher side, an immediate resistance is seen in the vicinity of 15,000-15,100 levels


BUY AJANTA PHARMA (Rs 1,863): | Target: Rs 2,050 | Stop-loss: Rs 1,755 | Potential return: 10%

The stock price has broken out on the daily line chart with higher volumes where it closed at three-year high. Oscillator like RSI is showing strength in the current uptrend of the stock. Plus, DI is placed above the Minus DI while ADX is placed above 20, Indicating momentum in the current uptrend. Pharma, as a sector, is looking good on the chart for the short-to-medium term. Therefore, we recommend buying Ajanta Pharma at CMP of Rs 1,863 for the target of 2,050, keeping a Stop Loss at 1,755

BUY GALAXY SURFACTANTS (Rs 2,446): | Target: Rs 2,750 | Stop-loss: Rs 2,300 | Potential return: 12%

The stock price has broken out on the daily line chart to close at all-time high levels. It is taking support at 20-day EMA since the last few days. Plus, DI is placed above the Minus DI while ADX is placed at 37, indicating momentum in the current uptrend. Volumes have been higher during the up days as compared to down days during the last few days, indicating accumulation in the stock. Therefore, we recommend buying Galaxy Surfactants at CMP of Rs 2,446 for the target of 2,750, keeping a Stop Loss at 2,300.



Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel